VYNE Therapeutics (NASDAQ: VYNE)
VYNE Therapeutics Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
VYNE Therapeutics Company Info
VYNE Therapeutics, Inc. engages in the manufacture of pharmaceutical products. It develops and commercialize solutions using its proprietary Molecule Stabilizing Technology. Its commercial products include AMZEEQ and ZILXI. The company was founded on October 21, and is headquartered in Bridgewater, NJ.
News & Analysis
Why VYNE Therapeutics Stock Is Crashing Today
The drugmaker reported disappointing Q1 results.
Can Vyne Therapeutics Stock Keep Soaring?
This biotech stock is jumping, but what should investors expect from its new skincare treatments?
Valuation
Earnings Transcripts
VYNE Therapeutics Inc. (VYNE) Q2 2021 Earnings Call Transcript
VYNE earnings call for the period ending June 30, 2021.
VYNE Therapeutics Inc. (VYNE) Q1 2021 Earnings Call Transcript
VYNE earnings call for the period ending March 31, 2021.
VYNE Therapeutics Inc. (VYNE) Q4 2020 Earnings Call Transcript
VYNE earnings call for the period ending December 31, 2020.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.